Open Journal Systems

Medicines development and regulation in Africa

Bernd Rosenkranz, Michael Reid, Elizabeth Allen

Article ID: 137
Vol 1, Issue 2, 2017, Article identifier:33–36

VIEWS - 670 (Abstract) 407 (PDF)

Abstract

Africa is one of the world’s fastest-growing economic regions, with a rise in its pharmaceutical industry value from $4.7 billion in 2003 to $20.8 billion in 2013. Multinational pharmaceutical companies are becoming more active in drug production and clinical trials across Africa, and there is an increase in the number of local companies engaged in medicines development and marketing. Such expansion of the local pharmaceutical industry requires trained pharmaceutical specialists to support it. The current situation and future requirements for local medicines development, regulation, education and training needs are discussed.

Keywords

medicines development; medicines regulation; Africa; training; education; PharmaTrain; IFAPP; SAHPRA

Full Text:

PDF


Included Database


References

McKinsey & Company Report, 2015, Insights into pharmaceuticals and medical products in Africa: A continent of opportunity for pharma and patients, viewed July 3, 2015,

World Health Organization Regional Office for Africa, 2014, Disease burden — Non-communicable diseases and conditions, viewed July 3, 2015,

Kahn M and Gastrow M, 2008, Pharmacologically active: Clinical trials and the pharmaceutical industry. South Africa Medical Journal, vol. 98(2): 114–116.

Strugo V, Katsoulis L, Chikoto H, et al. 2011, Conducting clinical trials in South Africa. In Chin R and Bairu M (eds), Global Clinical Trials (Chapter 13), Academic Press, 245–270. http://dx.doi.org/10.1016/B978-0-12-381537-8.10013-5

Isaakidis, P, Swingler, GH, Pienaar, E, et al. 2002, Relation between burden of disease and randomized evidence in sub-Saharan Africa: Survey of research. BMJ, vol.324(7339): 702–706. http://dx.doi.org/10.1136/bmj.324.7339.702

Siegfried N, Clarke M and Volmink J, 2005, Randomised controlled trials in Africa of HIV and AIDS: Descriptive study and spatial distribution. BMJ, vol.331(7519): 742–747. http://dx.doi.org/10.1136/bmj.331.7519.742

Rago L. Regulatory appraisal of biological medicines and harmonization initiatives for availability and access.

th World Congress of Basic and Clinical Pharmacology (WCP 2014), Cape Town, South Africa; Biological medicines development (PharfA Symposium 3)

Walubo A, Barnes K, Kwizera E, et al. 2013, Clinical Pharmacology becomes a specialty in South Africa. South African Medical Journal vol.103(3): 150–151. http://dx.doi.org/10.7196/SAMJ.6639

Fundisa African Academy of Medicines Development, 2015, viewed July 3, 2015,

The Global Health Network, 2015, Global health trials, viewed July 21, 2015,

Kerpel-Fronius S, Rosenkranz B, Allen E, et al. 2015, Education and training for medicines development, regulation and clinical research in emerging countries. Frontiers in Pharmacology, vol.6: 80. http://dx.doi.org/10.3389/fphar.2015.00080


DOI: http://dx.doi.org/10.18063/jmds.v1i2.137
(670 Abstract Views, 407 PDF Downloads)

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Bernd Rosenkranz, Michael Reid, Elizabeth Allen

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.